Oxford Cannabinoid Technologies Holdings Plc Stock
Equities
OCTP
GB00BMVMRB86
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.365 GBX | 0.00% | +4.29% | -41.60% |
Apr. 11 | Oxford Cannabinoid teams with iNGENu to test OCT130401 pain treatment | AN |
Apr. 09 | Oxford Cannabinoid Technologies Holdings plc Appoints Timothy Henry Corn as A Director | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 3.97M 4.98M |
---|---|---|---|---|---|
Net income 2024 * | -2M -2.51M | Net income 2025 * | -3M -3.76M | EV / Sales 2024 * | - |
Net cash position 2024 * | 1.18M 1.48M | Net Debt 2025 * | 2.03M 2.54M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.66
x | P/E ratio 2025 * |
-1.26
x | Employees | 7 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 70.17% |
1 week | +4.29% | ||
Current month | -15.12% | ||
1 month | -14.12% | ||
3 months | -49.66% | ||
6 months | -49.66% | ||
Current year | -41.60% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 44 | - | |
Paul Smalley
DFI | Director of Finance/CFO | - | 22-10-16 |
Chief Tech/Sci/R&D Officer | 55 | 20-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | - | |
Julie Pomeroy
CHM | Chairman | 69 | - |
Timothy Corn
CTO | Chief Tech/Sci/R&D Officer | 73 | 23-06-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 0.365 | 0.00% | 1 843 267 |
24-04-26 | 0.365 | -1.35% | 4,212,991 |
24-04-25 | 0.37 | +1.37% | 8,086,943 |
24-04-24 | 0.365 | +4.29% | 25,074,210 |
24-04-23 | 0.35 | 0.00% | 3,621,379 |
Delayed Quote London S.E., April 29, 2024 at 06:38 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.60% | 4.95M | |
+1.51% | 42.75B | |
+48.26% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- OCTP Stock